Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Reactive Oxygen Species Assay Kit for Live-Cell ROS
2026-09-16
Turn oxidative-stress biology into a measurable live-cell workflow with DCFH-DA fluorescence, Rosup validation, and plate-reader, imaging, or flow-cytometry readouts. The assay is especially useful for connecting PM2.5 exposure, Nrf2 activity, EGFR/PI3K/AKT signaling, and oxidative damage without treating a bulk ROS signal as a standalone mechanism.
-
Protein A/G Magnetic Co-IP/IP Kit for PINK1 Studies
2026-09-16
Translate UBC9–PINK1 biology into a reproducible co-IP workflow using magnetic separation, native lysate handling, and reciprocal controls. The kit also supports interaction screening, IP-Western validation, mass spectrometry preparation, and antibody purification using magnetic beads.
-
Cholesterol Hinders LNP Intracellular Trafficking
2026-09-15
A 2025 International Journal of Pharmaceutics study developed a high-sensitivity streptavidin–biotin–DNA tracking platform to resolve how lipid nanoparticle composition affects intracellular movement. Its central finding is that increasing cholesterol promotes aggregation of LNP-containing peripheral early endosomes, impairs progression through the endolysosomal pathway, and reduces nucleic acid delivery efficiency.
-
Isradipine (Dynacirc) in Calcium Research
2026-09-15
Isradipine (Dynacirc) is a dihydropyridine L-type calcium channel antagonist used to study vascular smooth muscle relaxation and calcium-dependent neuronal injury. Its product specifications support controlled formulation, storage, and assay integration, while neuronal channel literature defines important limits on subtype interpretation.
-
Perospirone Workflow for Receptor and Kv1.5 Studies
2026-09-14
Build a two-tier assay strategy with Perospirone (SM-9018 freebase): resolve nanomolar serotonergic and dopaminergic receptor pharmacology before testing micromolar vascular Kv1.5 effects. This workflow helps distinguish intended antipsychotic drug mechanism from concentration-dependent off-target activity in schizophrenia research and cardiovascular models.
-
Tofacitinib Citrate: JAK3 Research Guide
2026-09-14
Tofacitinib citrate, also called CP-690550 citrate, is a nanomolar JAK3-preferring research compound for immune regulation and inflammatory disorder research. Its cytokine and endothelial effects are concentration- and context-dependent, so immune-cell assays and vascular safety experiments require separate dose ranges.
-
Protein A/G Magnetic Co-IP/IP Kit for AP2-M Studies
2026-09-13
Discover how the Protein A/G Magnetic Co-IP/IP Kit can extend AP2-M research from DNA occupancy and transcriptomics to experimentally testable protein complexes. This article presents an orthogonal validation strategy for protein-protein interaction analysis in Babesia studies.
-
Superoxide Dismutase Activity Assay Kit Guide
2026-09-12
The Superoxide Dismutase Activity Assay Kit (SKU K2035) provides a colorimetric method for measuring SOD activity in biological fluids through inhibition of WST-1 reduction by assay-generated superoxide. It is intended for controlled research workflows, including oxidative stress assay and antioxidative enzyme assay applications, and must not be used for diagnosis or medical decision-making.
-
2-NBDG Workflows for Cellular Glucose Uptake
2026-09-11
Use 2-NBDG to convert transporter-mediated glucose entry into quantitative flow cytometry, microscopy, or plate-reader data. This workflow emphasizes cell-type-specific kinetics, solubility control, and the paired metabolic measurements needed to interpret uptake in cancer and disease models.
-
Nitrocefin: From Signal to β-Lactamase Inhibition
2026-09-11
Nitrocefin is more than a rapid chromogenic readout: it can connect β-lactamase enzymatic activity measurement with modern inhibitor discovery. This article explains how to interpret its colorimetric signal, translate computational peptide hits into functional experiments, and avoid common assay-design errors.
-
Indole-3-pyruvic Acid: Pathways and Protocols
2026-09-10
Indole-3-pyruvic acid (IPA) is a tryptophan-derived intermediate in indole-3-acetic acid biosynthesis and a preclinical modulator of AhR, UHRF1, and AMPK-linked biology. Its reported plant, immune, arthritis, and cancer activities are context-dependent and should not be interpreted as evidence of clinical efficacy.
-
KU-60019: An ATM Inhibitor for State-Aware Assays
2026-09-10
Explore how KU-60019, a selective ATM kinase inhibitor, can be used to dissect DNA damage response, radiosensitization, glioma invasion, and metabolism-linked vulnerabilities. This article translates ovarian cancer findings into rigorous, clearly bounded assay strategies without conflating model-specific evidence.
-
Pertussis Toxin: From cAMP to TH17 Assays
2026-09-09
Pertussis toxin is more than a classic cAMP perturbation tool: it can help researchers separate proximal G protein signaling from downstream immune phenotypes. This article connects its use in dendritic-cell assays with new mechanistic insights into TH17 transcriptional control while defining practical limits for interpretation.
-
AP20187: Chemical Inducer of Dimerization Workflows
2026-09-09
AP20187 enables dose-controlled fusion protein dimerization for conditional gene expression, regulated cell therapy, and metabolic signaling studies. This workflow-focused guide connects practical assay design with the senescent CAF findings in breast cancer research while clearly separating validated product uses from hypothesis-generating applications.
-
Enzyme-Induced Hypoxia and NLRP3 in Urothelial Cells
2026-09-09
Hudson and colleagues show that hypoxia duration determines whether rat urothelial cells mount an adaptive response or activate caspase-1-associated inflammation. The work identifies a ROS/TXNIP/NLRP3-linked mechanism and provides a time-resolved framework for modeling bladder outlet obstruction-related injury in vitro.